Nektar Therapeutics | NKTR - Ebitda

Stock Price
81.60
Daily Change
0.34 0.42%
Monthly
13.00%
Yearly
796.51%
Q2 Forecast
75.38

Nektar Therapeutics reported $-31.81M in EBITDA for its fiscal quarter ending in September of 2023.





Ebitda Change Date
Agios Pharmaceuticals USD -115.49M 10.3M Sep/2025
ALKERMES USD 100.31M 21.24M Dec/2025
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
Amgen USD 5.14B 775M Dec/2025
Baxter International USD 426M 36M Sep/2025
BioCryst Pharmaceuticals USD 51.7M 30.14M Sep/2025
Biogen USD 573.2M 253.7M Dec/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Cara Therapeutics USD -2.39M 3.16M Mar/2025
Cipla INR 12.55B 6.4B Dec/2025
Dr.Reddys Laboratories INR 20.89B 117M Dec/2025
Eisai JPY 30.1B 6.62B Dec/2025
Eli Lilly USD 7.88B 378.1M Sep/2025
Esperion Therapeutics USD -9.93M 24.99M Sep/2025
Exelixis USD 248.93M 28.02M Sep/2025
Gilead Sciences USD 4.03B 628M Sep/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
Grifols EUR 482.04M 7.04M Sep/2025
Halozyme Therapeutics USD 21.9M 226.34M Dec/2025
Incyte USD 414.5M 92.42M Dec/2025
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
Ironwood Pharmaceuticals USD 81.81M 31.71M Sep/2025
Karyopharm Therapeutics USD -26.2M 1.83M Sep/2024
MacroGenics USD 21.95M 55.39M Sep/2025
Merck USD 8.39B 1.97B Sep/2025
Nektar Therapeutics USD -31.81M 70K Sep/2023
Neurocrine Biosciences USD 218.4M 28.3M Dec/2025
Novartis USD 4.77B 1.11B Dec/2025
Pfizer USD 6.08B 351M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sarepta Therapeutics USD -168.03M 294.45M Sep/2025
Takeda JPY 448.13B 173.98B Dec/2025
Teva Pharmaceutical Industries USD 1.64B 243M Dec/2025
Xencor USD -51.05M 55.28M Dec/2025